[PDF] Top 20 Singing classes for chronic obstructive pulmonary disease: a randomized controlled trial

... rapid disease progression and reduced health status [31-33] so the absence of improvement in measures of physical activity was disappointing but may have been due to the small sample size, as responses were highly ... See full document

... The intensity-controlled VR sessions included games provided by the Kinect ® Adventures (Microsoft Game Studios, Washington, US). Patients participated in mini- games in which they performed certain movements in ... See full document

... the trial that included case manage- ment by a nurse as well as other interventions making it difficult to isolate the effect of the TM ...a Pulmonary specialist, visits to the Emergency Department, and ... See full document

... severe chronic hypoxemia refractory to maximal treatment with bron- chodilator and anti-inflammatory drugs, smoking cessa- tion and long-term oxygen therapy are the only two interventions that have unequivocally ... See full document

... A PubMed literature search (restricted to English literature; no date restriction) using the terms COPD (MeSH) and salmeterol or formoterol or tiotropium was carried out on May 14, 2009, and yielded 223 articles (search ... See full document

... double-blind, randomized, controlled trial, COPD patients were allocated into groups that either received paroxetine 20 mg or placebo pills daily, for four ... See full document

... terms: randomized controlled trial; controlled clinical trial; randomized; chronic obstructive pulmonary disease; long-acting beta agonist (LABA); ... See full document

... Epidemiological studies of COPD on a representative sample have not been performed in Poland, but esti- mates from smaller studies suggested a relatively high prevalence. Studies in selected geographical areas found that ... See full document

... with chronic heart failure due to ischemic or idiopathic dilated ...and pulmonary vascular resistance for the right ventricle) on thermal vaso- dilatation after Waon ...and pulmonary artery pressure ... See full document

... advanced disease, both malignant and non- malignant. In chronic obstructive pulmonary disease (COPD) and heart failure it is nearly universal by the time of death, its prevalence ... See full document

... The trial is designed as a randomised controlled trial and fulfils the requirements of the Standard Protocol Items: Recommendations for Interventional Trials (SPIRIT) checklist [21] (Additional file ... See full document

... Disease in Very Low Birth Weight Infants: A Randomized, Controlled Trial Effects of Early Dexamethasone Therapy on Pulmonary Mechanics and Chronic Lung. http://pediatrics.aappublications[r] ... See full document

... to pulmonary rehabilitation had a greater retention of par- ticipants (8/81 withdrawn) ...completed pulmonary rehabilitation and they made this a core component of the ... See full document

... Current interventions for COPD (such as smoking cessation, rehabilitation, nutrition support, drug treat- ments and psychosocial aids) are mainly on a case-by- case basis among patients who have already developed ... See full document

... Our findings suggest that TM has a potential role in improv- ing the QoL of COPD patients overall, despite not improving symptoms and exacerbations, and not least in patients with a lower than median score of QoL. We ... See full document

... As the population ages, COPD prevalence is likely to increase, emphasizing the need for health care systems to recognize patterns of comorbidity associated with COPD. Although there is no firm evidence to support the ... See full document

... Methods: All consecutive patients admitted between June and November 2000 in the medical-surgical intensive care unit, who required mechanical ventilation for more than 24 h because of acute respiratory failure, were ... See full document

... However, valuable observations were made in both studies. First, a significant effect of the ICS/LABA was observed on moderate and severe exacerbations even in patients without a history of exacerbations, particularly in ... See full document

... COPD severity could play a role as well. Since patients with a higher burden of disease have more room for improvement, they might benefit more from case man- agement. Due to the small sample size of our pilot ... See full document

... heterogeneous disease, in which several factors combine to give the final clinical ...the disease, FEV 1 is a poor surrogate marker for symptoms ...observational controlled multicenter international ... See full document